Adele Hosseini

Scientifically Validated Applications of a CBD-Dominant Medicine for Clinical Practice – Using Real-World Evidence to Support Patient Outcome

A Talk by Dr Adele Hosseini B.Pharm, M.Pharm, PhD (Chief Scientific Officer, Bod Australia)

About this Talk

In this presentation, Dr. Hosseini details the clinic applications of a specific CBD-dominant medicine based on validated phase-IV research on the use of the medicine in practice. In-depth discussion on specific patient case studies dosage and patient specific outcomes. The importance of quality, cannabinoid consistency, and source are also discussed in relation to the role in patient care and relevance to medicine assessment.

25 November 2021, 11:40 PM

11:40 PM - 12:40 AM

About The Speakers

Adele Hosseini

Dr Adele Hosseini B.Pharm, M.Pharm, PhD

Chief Scientific Officer, Bod Australia

Dr. Adele Hosseini, Chief Scientific Officer for Bod Australia, is pioneering into medicinal cannabis for commercialisation.